Guided Self-Help for Depression in Parkinson's Disease



Status:Completed
Conditions:Depression, Depression, Parkinsons Disease
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:35 - 85
Updated:12/14/2017
Start Date:April 2013
End Date:April 2016

Use our guide to learn which trials are right for you!

A Guided Cognitive-Behavioral Self-Help Treatment for Depression in Parkinson's Disease

The purpose of this project is to develop and pilot-test a guided cognitive-behavioral
self-help program for mild-to-moderate depression in Parkinson's disease (dPD). We will
pilot-test the guided self-help treatment on 20 people with PD and their caregivers. The
manual will be revised based on participant feedback. Several feasibility measures regarding
the guided self-help program (i.e., recruitment, retention, enjoyment, helpfulness,
adherence) will also be assessed. Moreover, preliminary estimates of effect size for this
guided self-help program will be calculated and used in future research. We hypothesize that
people with PD will report decreases in depression, anxiety, and negative thoughts and
improvements in quality life and sleep and that caregivers will report decreases in burden
after participating in the guided self-help program

To our knowledge, Cognitive-Behavioral self-help interventions remain unexplored for
depression in PD to date. The results of this study will be used to support future treatment
development efforts for depression and other psychiatric complications in PD that may improve
the access to and quality of mental health care in this medical population.

Inclusion Criteria:

1. Previous diagnosis of Parkinson's disease by a general neurologist or Movement
Disorders Specialist

2. Clinically significant depression as determined by study staff

3. 35-85 years old

4. Stable medication regimen ≥ 6 weeks

5. No change in mental health treatment in past 2 months _

Exclusion Criteria:

1. Severe depressive symptoms

2. Suicidal plans or intent

3. Significant cognitive impairment

4. Significant motor fluctuations (i.e., ≥ 50% of the day)

5. Unstable medical conditions

6. Receiving CBT elsewhere
We found this trial at
1
site
Piscataway, New Jersey 08854
Principal Investigator: Roseanne D Dobkin, PhD
Phone: 732-235-4051
?
mi
from
Piscataway, NJ
Click here to add this to my saved trials